Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Dolutegravir ( Tivicay )
Dolutegravir ( Tivicay )
by brown
Prepared by:. Brian R. Wood, MD. David H. Spach, M...
Dolutegravir vs. Raltegravir
Dolutegravir vs. Raltegravir
by zoe
SPRING-2 Study. Dolutegravir. versus Raltegravir....
Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs
Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs
by roxanne
FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir ...
2013 Asilomar HIV Medical Update
2013 Asilomar HIV Medical Update
by luanne-stotts
David Spach, MD. Clinical Director, Northwest AET...
Update from CROI 2023: Snippets from Seattle
Update from CROI 2023: Snippets from Seattle
by scarlett
Judith S. Currier, MD, MSc. Professor of Medicine....
Dolutegravir-Lamivudine (
Dolutegravir-Lamivudine (
by audrey
Dovato. ). Last Updated: November 28, 2022. Prepar...
Working Group on Modelling Potential Responses to High Levels of pre-ART Drug Resistance in Sub-Sah
Working Group on Modelling Potential Responses to High Levels of pre-ART Drug Resistance in Sub-Sah
by debby-jeon
HIV Drug Resistance (HIVDR) and Antimicrobial Res...
HIV 2015-2016: New Agents, New Strategies
HIV 2015-2016: New Agents, New Strategies
by ellena-manuel
Learning Objectives. EARLY VS DEFERRED ART. The C...
HIV Pharmacotherapy Focused Update
HIV Pharmacotherapy Focused Update
by yoshiko-marsland
Drew Lambert, . PharmD. lambertd@husson.edu. Huss...
Essentials for Optimal Care of HIV Patients
Essentials for Optimal Care of HIV Patients
by marina-yarberry
Evidence-Based Approaches. Simply Speaking. ®. ...
Heather Watts MD Director of HIV Prevention, Program Quality Team
Heather Watts MD Director of HIV Prevention, Program Quality Team
by alida-meadow
Heather Watts MD Director of HIV Prevention, Pro...
Interactive ART Cases From the Clinic: Is There One Right Answer?
Interactive ART Cases From the Clinic: Is There One Right Answer?
by megan
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Antiretroviral Updates:
Antiretroviral Updates:
by tatyana-admore
New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...
Cases from the Clinic(ians): Case-based Panel Discussion
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents
Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents
by ethlyn
Linda Barlow-Mosha*. 1. , Grace Miriam . Ahimbisib...
Dolutegravir monotherapy
Dolutegravir monotherapy
by alexa-scheidler
Dolutegravir monotherapy vs. dolutegravir/ abac...
ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals
ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals
by phoebe-click
ACTIVITY CODE . TD342. Antiretroviral Medications...
Projecting the Impact of
Projecting the Impact of
by marina-yarberry
Generic. HIV . Drugs. on 90-90-90. Esteban Burr...